The traditional biopharma approach focused primarily on physician detailing and securing favorable payer contracts, has become inadequate in today’s market.
Lauren Nestor
Advertisement
Articles by Lauren Nestor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
How Will FDA's Priority Review Program Impact Domestic Manufacturing?
4
Aidoc Submits Breakthrough-Designated Multi-Triage Device for FDA Approval
5
